NCT02470026View on ClinicalTrials.gov

Noradrenergic Activity, Cognition and Major Depressive Disorder

NACompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

October 31, 2018

Conditions
Major Depressive DisorderEarly Life Trauma
Interventions
DRUG

yohimbine

single low dose treatment

DRUG

placebo

single control treatment

Trial Locations (1)

Unknown

Charite University, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT02470026 - Noradrenergic Activity, Cognition and Major Depressive Disorder | Biotech Hunter | Biotech Hunter